Chris Rallis
Directeur/Membre du Conseil chez AEOLUS PHARMACEUTICALS, INC.
Fortune : 434 642 $ au 30/04/2024
Profil
Chris A.
Rallis currently works at Fennec Pharmaceuticals, Inc., as Independent Director from 2011, Aeolus Pharmaceuticals, Inc., as Independent Director from 2004, and Salisbury School, Inc., as Director.
Mr. Rallis also formerly worked at ImmunoBiosciences, Inc., as President & Chief Executive Officer from 2006 to 2007, ImmunoBiosciences, Inc., as President & Chief Executive Officer, Tenax Therapeutics, Inc., as Independent Director from 2011 to 2021, Triangle Pharmaceuticals, Inc., as President, Chief Operating Officer & Director from 1995 to 2003, Incara Pharmaceuticals Corp., as Director, Soligenix, Inc., as Director, EMD Millipore Corp., as Director, Lee's Pharmaceutical Holdings Ltd., as Director, Naicons Srl, as Director, and Burroughs Wellcome, as VP-Strategic Planning & Business Development.
Mr. Rallis received his graduate degree from Duke University and undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
29/04/2024 | 47 450 ( 0,18% ) | 434 642 $ | 30/04/2024 |
Postes actifs de Chris Rallis
Sociétés | Poste | Début |
---|---|---|
AEOLUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/06/2004 |
FENNEC PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 25/08/2011 |
Salisbury School, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Chris Rallis
Sociétés | Poste | Fin |
---|---|---|
TENAX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/06/2021 |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Directeur Général | 01/06/2007 |
Incara Pharmaceuticals Corp. | Directeur/Membre du Conseil | 09/08/2004 |
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | President | 01/01/2003 |
Naicons Srl
Naicons Srl Packaged SoftwareTechnology Services Naicons Srl develops a game-changing drug discovery platform. The private company is based in Milan, Italy. | Directeur/Membre du Conseil | - |
Formation de Chris Rallis
Duke University | Graduate Degree |
Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
AEOLUS PHARMACEUTICALS, INC. | Health Technology |
FENNEC PHARMACEUTICALS INC. | Health Technology |
TENAX THERAPEUTICS, INC. | Health Technology |
SOLIGENIX, INC. | Health Technology |
LEE'S PHARMACEUTICAL HOLDINGS LIMITED | Health Technology |
Entreprise privées | 7 |
---|---|
Incara Pharmaceuticals Corp. | Health Technology |
Burroughs Wellcome | |
ImmunoBiosciences, Inc.
ImmunoBiosciences, Inc. Packaged SoftwareTechnology Services ImmunoBiosciences, Inc. develops a vaccine platform technology solution. The company is headquartered in Raleigh, NC. | Technology Services |
Triangle Pharmaceuticals, Inc.
Triangle Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Triangle Pharmaceuticals Inc. provided antiviral drug candidates for the human immunodeficiency virus. The company was founded in 1995 and was located in Durham, NC. | Commercial Services |
Salisbury School, Inc. | |
EMD Millipore Corp.
EMD Millipore Corp. Miscellaneous Commercial ServicesCommercial Services EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA. | Commercial Services |
Naicons Srl
Naicons Srl Packaged SoftwareTechnology Services Naicons Srl develops a game-changing drug discovery platform. The private company is based in Milan, Italy. | Technology Services |